Clinical Trial Update: A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two initial dose prescriptions for Exubera (insulin human inhalation powder) in Type 2 diabetes was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2009-03-06